Skip to main content
OpenTrials
Completed

NCT Number: NCT03240952

The Nutritional Health for the Elderly Reference Centre Study (NHERC Study)

Elderly are at greater risk of dietary insufficiency due to age-related increases in nutrient requirements concomitant with a reduction in energy requirements, decreases in appetite and energy intake. Currently there is a gap in knowledge of the factors that are associated with malnutrition in the elderly in Singapore. In addition, there is no "reference" database on anthropometric measurements and biochemical indices for elderly with a range of nutrition status in Singapore. Thus, the objectives of this cross-sectional study are to examine factors influencing nutritional status and to determine the reference values for anthropometric and biochemical measurements related to nutritional status for community-dwelling elderly in Singapore.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Malnutrition Nutrition Disorders Nutritional and Metabolic Diseases

Age range

65 year–110 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Bedok Polyclinic, Singapore

Loading trial locations.

About this study

This is a cross-sectional study. Measurements will be taken at baseline for elderly with normal nutrition (n = 400) and elderly who are at risk of under nutrition (n = 800).. These measurements will be used to examine factors influencing nutritional status and to create a "reference" database for anthropometric and biochemical measurements related to nutritional status for use in clinical practice.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female participant aged ≥65 years.
  • Community-dweller, i.e. not staying in a residential intermediate and long-term care (ILTC) service institution.
  • Participant is being discharged home directly (applicable for hospital cohort).
  • Participant is community ambulant with or without aid.
  • Participant does not have any chronic disease(s) or has stable chronic disease(s) including hypertension, chronic obstructive pulmonary disease, and cardiovascular disease in the opinion of the Study Physician, at study entry.
  • Participant has voluntarily signed and dated an informed consent form (ICF), approved by an Institutional Review Board (IRB) and provided authorization prior to any participation in the study.
  • Participants will be able to communicate and follow instructions.
  • Participant is able to consume food and beverages orally.

Exclusion criteria

  • Participant has been diagnosed with dementia according to medical records.
  • Participant has been diagnosed with type 1 or type 2 diabetes according to medical records. (Note: This includes participant with controlled diabetes.)
  • Participant has any active infectious disease (such as tuberculosis, Hepatitis B or C, HIV infection) according to medical records.
  • Participant has been diagnosed with severe gastrointestinal disorders including celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic fibrosis according to medical records.
  • Participant has been diagnosed with end stage organ or pre-terminal diseases or acute myocardial infarction within the last 30 days from the screening according to medical records.
  • Participant has malignancy according to medical records.
  • Participant has any other clinically significant medical condition, which in the investigator's opinion, makes him or her unsuitable for inclusion in the study.
  • Participant is taking part in another study that has not been approved as a concomitant study by the study team.

Treatment and study plan

Primary outcomes

  1. MUST

    Time frame: Baseline

    Malnutrition risk using Malnutrition Universal Screening Tool

Secondary outcomes

  1. Body weight, fat mass, fat free mass

    Time frame: Baseline

    Body weight, fat mass, fat free mass in kilograms will be measured using Tanita MC-780

  2. Pre-albumin

    Time frame: Baseline

    Pre-albumin in mg/dL will be measured using Cobas

  3. Albumin and total protein

    Time frame: Baseline

    Albumin and total protein in g/L will be measured using Cobas

Sponsors and collaborators

Lead sponsor

Abbott Nutrition

Industry

Collaborators

  • Changi General Hospital
  • SingHealth Polyclinics

Registry information

Official study title

Establishing Reference Range for Community-dwelling Elderly Nutrition

Acronym: NHERC

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Aug 7, 2017
Registry last updated
Apr 15, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.